InvestorsHub Logo
Followers 62
Posts 7601
Boards Moderated 1
Alias Born 01/02/2003

Re: None

Wednesday, 07/12/2023 2:17:18 PM

Wednesday, July 12, 2023 2:17:18 PM

Post# of 428687
Vascepa's largest competitor is not gV and not Lovaza...It is fish oil...which has far more sales than Vascepa, being sold in volume in every supermarket...and fish oil has been proven to be NOT helpful in reducing CVD events, plus it does not have Vascepa's many other beneficial effects...Amarin, somehow has to get the word out that Vascepa has been proven to provide many real health benefits that fish oil can not.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News